Copyright Reports & Markets. All rights reserved.

Global HPV Vaccines Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 HPV Vaccines Market Overview

      • 1.1 Product Overview and Scope of HPV Vaccines
      • 1.2 HPV Vaccines Segment by Type
        • 1.2.1 Global HPV Vaccines Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Adolescents
        • 1.2.3 Adults
      • 1.3 HPV Vaccines Segment by Application
        • 1.3.1 HPV Vaccines Consumption Comparison by Application (2014-2025)
        • 1.3.2 Male
        • 1.3.3 Female
      • 1.4 Global HPV Vaccines Market by Region
        • 1.4.1 Global HPV Vaccines Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global HPV Vaccines Market Size
        • 1.5.1 Global HPV Vaccines Revenue (2014-2025)
        • 1.5.2 Global HPV Vaccines Production (2014-2025)

      2 Global HPV Vaccines Market Competition by Manufacturers

      • 2.1 Global HPV Vaccines Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global HPV Vaccines Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global HPV Vaccines Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers HPV Vaccines Production Sites, Area Served, Product Types
      • 2.5 HPV Vaccines Market Competitive Situation and Trends
        • 2.5.1 HPV Vaccines Market Concentration Rate
        • 2.5.2 HPV Vaccines Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global HPV Vaccines Production Market Share by Regions

      • 3.1 Global HPV Vaccines Production Market Share by Regions
      • 3.2 Global HPV Vaccines Revenue Market Share by Regions (2014-2019)
      • 3.3 Global HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America HPV Vaccines Production
        • 3.4.1 North America HPV Vaccines Production Growth Rate (2014-2019)
        • 3.4.2 North America HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe HPV Vaccines Production
        • 3.5.1 Europe HPV Vaccines Production Growth Rate (2014-2019)
        • 3.5.2 Europe HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China HPV Vaccines Production (2014-2019)
        • 3.6.1 China HPV Vaccines Production Growth Rate (2014-2019)
        • 3.6.2 China HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan HPV Vaccines Production (2014-2019)
        • 3.7.1 Japan HPV Vaccines Production Growth Rate (2014-2019)
        • 3.7.2 Japan HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global HPV Vaccines Consumption by Regions

      • 4.1 Global HPV Vaccines Consumption by Regions
      • 4.2 North America HPV Vaccines Consumption (2014-2019)
      • 4.3 Europe HPV Vaccines Consumption (2014-2019)
      • 4.4 China HPV Vaccines Consumption (2014-2019)
      • 4.5 Japan HPV Vaccines Consumption (2014-2019)

      5 Global HPV Vaccines Production, Revenue, Price Trend by Type

      • 5.1 Global HPV Vaccines Production Market Share by Type (2014-2019)
      • 5.2 Global HPV Vaccines Revenue Market Share by Type (2014-2019)
      • 5.3 Global HPV Vaccines Price by Type (2014-2019)
      • 5.4 Global HPV Vaccines Production Growth by Type (2014-2019)

      6 Global HPV Vaccines Market Analysis by Applications

      • 6.1 Global HPV Vaccines Consumption Market Share by Application (2014-2019)
      • 6.2 Global HPV Vaccines Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in HPV Vaccines Business

      • 7.1 Astellas Pharma
        • 7.1.1 Astellas Pharma HPV Vaccines Production Sites and Area Served
        • 7.1.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.1.3 Astellas Pharma HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 CSL
        • 7.2.1 CSL HPV Vaccines Production Sites and Area Served
        • 7.2.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.2.3 CSL HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Emergent BioSolutions
        • 7.3.1 Emergent BioSolutions HPV Vaccines Production Sites and Area Served
        • 7.3.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.3.3 Emergent BioSolutions HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 GlaxoSmithKline
        • 7.4.1 GlaxoSmithKline HPV Vaccines Production Sites and Area Served
        • 7.4.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.4.3 GlaxoSmithKline HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Johnson & Johnson
        • 7.5.1 Johnson & Johnson HPV Vaccines Production Sites and Area Served
        • 7.5.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.5.3 Johnson & Johnson HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 MedImmune
        • 7.6.1 MedImmune HPV Vaccines Production Sites and Area Served
        • 7.6.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.6.3 MedImmune HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Merck
        • 7.7.1 Merck HPV Vaccines Production Sites and Area Served
        • 7.7.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.7.3 Merck HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Pfizer
        • 7.8.1 Pfizer HPV Vaccines Production Sites and Area Served
        • 7.8.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.8.3 Pfizer HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Sanofi Pasteur
        • 7.9.1 Sanofi Pasteur HPV Vaccines Production Sites and Area Served
        • 7.9.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.9.3 Sanofi Pasteur HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Serum Institute
        • 7.10.1 Serum Institute HPV Vaccines Production Sites and Area Served
        • 7.10.2 HPV Vaccines Product Introduction, Application and Specification
        • 7.10.3 Serum Institute HPV Vaccines Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 HPV Vaccines Manufacturing Cost Analysis

      • 8.1 HPV Vaccines Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of HPV Vaccines
      • 8.4 HPV Vaccines Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 HPV Vaccines Distributors List
      • 9.3 HPV Vaccines Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global HPV Vaccines Market Forecast

      • 11.1 Global HPV Vaccines Production, Revenue Forecast
        • 11.1.1 Global HPV Vaccines Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global HPV Vaccines Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global HPV Vaccines Price and Trend Forecast (2019-2025)
      • 11.2 Global HPV Vaccines Production Forecast by Regions (2019-2025)
        • 11.2.1 North America HPV Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe HPV Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.3 China HPV Vaccines Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan HPV Vaccines Production, Revenue Forecast (2019-2025)
      • 11.3 Global HPV Vaccines Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America HPV Vaccines Consumption Forecast (2019-2025)
        • 11.3.2 Europe HPV Vaccines Consumption Forecast (2019-2025)
        • 11.3.3 China HPV Vaccines Consumption Forecast (2019-2025)
        • 11.3.4 Japan HPV Vaccines Consumption Forecast (2019-2025)
      • 11.4 Global HPV Vaccines Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global HPV Vaccines Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer. They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection.
        HPV vaccine is an inactivated (not live) vaccine which protects against four major types of HPV. These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Human papillomaviruses (HPVs) are a group of more than 200 related viruses. More than 40 HPV types can be easily spread through direct sexual contact, from the skin and mucous membranes of infected people to the skin and mucous membranes of their partners. They can be spread by vaginal, anal, and oral sex (1). Other HPV types are responsible for non-genital warts, which are not sexually transmitted. The segment of Female HPV vaccine market witnessed growth at a noteworthy rate over the past few years and is expected to grow in the forecast period on the back of rising awareness regarding HPV related fatal diseases, rising healthcare expenditures along with rising disposable incomes. North America and Europe accounts for the maximum market share of the global HPV vaccines market and is expected to grow at highest CAGR during the forecast period.

        The global HPV Vaccines market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on HPV Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall HPV Vaccines market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Astellas Pharma
        CSL
        Emergent BioSolutions
        GlaxoSmithKline
        Johnson & Johnson
        MedImmune
        Merck
        Pfizer
        Sanofi Pasteur
        Serum Institute

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Adolescents
        Adults

        Segment by Application
        Male
        Female

        Buy now